SCHEMBL2179019

SCHEMBL2179019

Cc1cc(N(C(=O)OC(C)(C)C)c2ccc(C#N)cc2)ccc1Br

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MT-CO2 P00403 1/20 0.35
CHRNB2 P17787 2/20 0.34
CHRNB4 P30926 2/20 0.34
CHRNA3 P32297 2/20 0.34
CHRNA4 P43681 2/20 0.34
GPR119 Q8TDV5 2/20 0.33
NCEH1 Q6PIU2 1/20 0.33
EGLN2 Q96KS0 1/20 0.32
CYP19A1 P11511 1/20 0.32
CHRNA1 P02708 1/20 0.32
CHRNG P07510 1/20 0.32
CHRNB1 P11230 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
CHRND Q07001 1/20 0.32
ABCB1 P08183 2/20 0.31
SCN9A Q15858 1/20 0.31
AR P10275 1/20 0.31
PGR P06401 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2178410 0.85 CHRNB2 (0.37) MT-CO2CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL2354020 0.82 CYP19A1 (0.36) CYP19A1ARGAA
SCHEMBL2180329 0.81 CHRNB2 (0.34) MT-CO2CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL2178837 0.77 GAA (0.35) MT-CO2GAA
SCHEMBL3868314 0.76 CHRNB2 (0.41) MT-CO2CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL1163580 0.74 MEN1 (0.44) MT-CO2
SCHEMBL6650593 0.74 CHRNB2 (0.42) CHRNB2CHRNB4CHRNA3CHRNA4GPR119
SCHEMBL17878846 0.74 KCNH2 (0.39) GPR119EGLN2SLC6A2ABCB1SCN9A
SCHEMBL12484843 0.72 PDE4B (0.53)
SCHEMBL922803 0.72 MT-CO2 (0.46) MT-CO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130289000-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS INC (US) 2013-10-31 US disclosed
US-8470803-B2 Boron-containing small molecules ANACOR PHARMACEUTICALS, INC. (US) 2013-06-25 US disclosed
US-20110166103-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166103-A1 BORON-CONTAINING SMALL MOLECULES NFKBIA, BCL6B, TNF MT-CO2 4815/4885CHRNB2 3527/4885CHRNB4 3916/4885
US-20130289000-A1 BORON-CONTAINING SMALL MOLECULES NFKBIA, BCL6B, TNF MT-CO2 4815/4885CHRNB2 3527/4885CHRNB4 3916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.